| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/22/2007 | US20070042975 Novel indolopyrrolocarbazole derivative with antitumor activity |
| 02/22/2007 | US20070042974 Nozel azalide and azalactam derivatives and method for producing the same |
| 02/22/2007 | US20070042973 Treatment of pain and fever |
| 02/22/2007 | US20070042972 Compositions and methods for optimizing exercise recovery |
| 02/22/2007 | US20070042971 Crystalline compound of 4'-demethyl-4'-phosphate-2", 3"-bispentafluorophenoxy-acetyl-4", 6"-ethylidene-beta-d-epipodophyllotoxin glucoside either in its free form or solvated with ethanol |
| 02/22/2007 | US20070042970 Folate-modified cholesterol-bearing pullulan as a drug carrier |
| 02/22/2007 | US20070042969 Peptides such as Lacosamide with analgesic, an anticonvulsant, an antidepressant or an NMDA receptor antagonist |
| 02/22/2007 | US20070042967 Proteaseome inhibitors for the treatment of herpesviridae infected individuals |
| 02/22/2007 | US20070042957 Type v phosphodiesterase inhibitors and natriuretic polypeptides |
| 02/22/2007 | US20070042955 Abuse-resistant amphetamine prodrugs |
| 02/22/2007 | US20070042953 Antiepileptogenic complex of albumin with docosahexaenoate |
| 02/22/2007 | US20070042951 Pharmaceutical compositions comprising alpha-2-adrenergics and trefoil factor family peptides |
| 02/22/2007 | US20070042947 Agents for preventing and/or treating uppper digestive tract disorders |
| 02/22/2007 | US20070042943 Cyclosporin active, fatty acid triglyceride, glycerol fatty acid partial ester or propylene glycol or sorbitol complete or partial ester, preferably, and a tenside having an HLB of at least 10; immunosuppressant, anti inflammatory, anti parasitic |
| 02/22/2007 | US20070042940 Modified 2' and 3'-nucleoside prodrugs for treating flaviviridae infections |
| 02/22/2007 | US20070042939 Hepatitis C; antivirals; 8-modified,1', 2', 3' or 4'-branched purine nucleoside; treating HCV infection |
| 02/22/2007 | US20070042937 Inhibitors of 2-oxoglutarate dioxygenase as gamma globin inducers |
| 02/22/2007 | US20070042936 glycerol cyclic pyruvate derivates; inhibit the binding of an immobilized D-proline derivative to serum amyloid P componen; amyloidosis; Alzheimers disease; maturity onset diabetes mellitus |
| 02/22/2007 | US20070042935 Quinazolinone-derivatives and their use for preparation of pharmaceutical compositions having parp enzyme inhibitory effect |
| 02/22/2007 | US20070042492 Amino acid sequences for transferring substances of interest from outside medium to inside of cells, specifically cell nuclei; useful for enhancing delivery of drugs into cytoplasm and/or the cell nucleus from the host organism being treated |
| 02/22/2007 | US20070042447 Use of anti-ferritin monoclonal antibodies in the treatment of some cancers (divisional) |
| 02/22/2007 | US20070042446 Drug screening; for inhibiting apoptosis in mammalian cells; zinc finger domains; consensus sequences; genetic engineering; for treating AIDS, alzheimer's disease, parkinson's disease, amyotrophic lateral sclerosis (ALS), retinitis pigmentosa, autoimmune diseases |
| 02/22/2007 | US20070042439 Porphyrin compound containing biotinyl group and use thereof |
| 02/22/2007 | US20070042437 Diagnosis and treatment of Alzheimer's Disease |
| 02/22/2007 | US20070042356 Variants of hepatitis B virus resistant against some nucleoside analogues, but sensitive to others, and uses thereof |
| 02/22/2007 | US20070042063 Protein kinase modulation by hops and acacia products |
| 02/22/2007 | US20070042061 fortified with essential oils; for treatment of rheumatoid arthritis, asthma, inflammatory bowel disease, Crohn's disease, ulcerative colitis, multiple sclerosis, psoriasis and skin rushes, chronic obstructive pulmonary disease, allergic rhinitis, cardiovascular disease, lupus and metabolic syndrome |
| 02/22/2007 | US20070042060 Methods to treat one or all of the defined etiologies of female sexual Dysfunction |
| 02/22/2007 | US20070042057 Compositions for the treatment and prevention of diabetes mellitus |
| 02/22/2007 | US20070042056 Anti-stress agent |
| 02/22/2007 | US20070042048 Devices, Compositions and Methods for the Pulmonary Delivery of Aerosolized Medicaments |
| 02/22/2007 | US20070042046 Methods for the treatment of cancer |
| 02/22/2007 | US20070042043 Pellet formulations of acid-labile benzimidazonle compounds |
| 02/22/2007 | US20070042042 Metformin Tablet with Sustained Release and Method for Preparing the Same |
| 02/22/2007 | US20070042041 Drug-surfactant complexes for sustained release |
| 02/22/2007 | US20070042040 Methods and compositions using gonadotropin hormone releasing hormone |
| 02/22/2007 | US20070042038 Progestin co-micronized with a surfactant, pharmaceutical composition comprising same, methods for making same and uses thereof |
| 02/22/2007 | US20070042037 Pharmaceutical composition containing levodopa and carbidopa |
| 02/22/2007 | US20070042034 High drug load formulations and dosage forms |
| 02/22/2007 | US20070042033 Pantoprazole multiparticulate formulations |
| 02/22/2007 | US20070042032 Self forming, thermodynamically stable liposomes and their applications |
| 02/22/2007 | US20070042023 Dissolvable film |
| 02/22/2007 | US20070042020 Composition for the treatment of dysfunctional energy metabolism syndrome |
| 02/22/2007 | US20070042019 Method of treating or preventing chronic wounds and a complete nutritional composition comprising glycine and/or leucine for use therein |
| 02/22/2007 | US20070042015 Coating composition for polymeric surfaces comprising serpin or serpin derivatives |
| 02/22/2007 | US20070042014 Combination of a serotonin reuptake inhibitor and loxapine |
| 02/22/2007 | US20070042010 Compositions containing amines and use thereof to treat acne or reduce the appearance of oil or pores on the skin |
| 02/22/2007 | US20070042009 Topical composition for delivery of salicylates |
| 02/22/2007 | US20070042008 Compositions containing phosphatidylcholine and essential fatty acids |
| 02/22/2007 | US20070042007 Topical composition for delivery of salicylate esters |
| 02/22/2007 | US20070042006 Stable carprofen composition |
| 02/22/2007 | US20070042004 Methods of Treating A Bacterial Infection using F. Tularensis Lipopolysaccharide |
| 02/22/2007 | US20070042003 Method of effecting a mammalian model of sepsis, severe sepsis, or septic shock |
| 02/22/2007 | US20070041968 Methods of inducing an immune response |
| 02/22/2007 | US20070041957 Stimulating formation of an inner ear sensory hair cell for treatment of sensorineuronal hearing loss; deafness |
| 02/22/2007 | US20070041956 Vaccine immunotherapy for immune suppressed patients |
| 02/22/2007 | US20070041939 Modified cytokines for use in cancer therapy |
| 02/22/2007 | US20070041935 Conformable solvent-based bandage and coating material |
| 02/22/2007 | US20070041934 Dendrimer based compositions and methods of using the same |
| 02/22/2007 | US20070041933 Functionally Diverse Macromolecules and Their Synthesis |
| 02/22/2007 | US20070041931 Compositions Comprising Soy Products and Dioic Acids |
| 02/22/2007 | US20070041916 Preparation containing diol |
| 02/22/2007 | US20070041915 Use of a biguanide derivative for protecting skin against uvb radiation |
| 02/22/2007 | US20070041912 Trospium containing compositions |
| 02/22/2007 | US20070041911 Hfc solution formulations containing salbutamol hydrochloride or salbutamol citrate |
| 02/22/2007 | US20070041910 Pharmaceutical spray compositions comprising a bioactive agent, at least one volatile silicone and a non-volatile oily phase |
| 02/22/2007 | US20070041905 Method of treating depression using a TNF-alpha antibody |
| 02/22/2007 | US20070041901 2'-O-methyl substituted nucleic acids specific to prostate specific membrane antigen (PSMA) for use in detection and targeting cancer tissues |
| 02/22/2007 | US20070041866 Aqueous solution of olanexidine, method of preparing the aqueous solution, and disinfectant |
| 02/22/2007 | DE69530936C5 Boronsäure-und-esterverbindungen, deren systhese und verwendungen Boronic acid and ester compounds whose systhese and uses |
| 02/22/2007 | DE202006018834U1 Zusammensetzung mit einem Getreidemahlerzeugnis Composition with a grain milling product |
| 02/22/2007 | DE102006005221B3 Use of 1-arylisochroman derivative having cell proliferation inhibitory activity to treat or prevent cancer such as glioblastoma or glioma |
| 02/22/2007 | DE102005038831A1 New N-acylalkoxycarbonyl-piperidine derivatives, useful as CGRP antagonists, for treating e.g. headaches, cardiovascular disease, skin disorders, morphine tolerance, and inflammatory diseases such as osteoarthritis and allergic rhinitis |
| 02/22/2007 | DE102005038537A1 1-Acyldihydropyrazolderivate 1 Acyldihydropyrazolderivate |
| 02/22/2007 | DE10101522B4 Neue pharmazeutische Verwendung einer Kombination aus Ascorbat und mindestens einem Fibrinolysehemmer New pharmaceutical use a combination of ascorbate and at least one Fibrinolysehemmer |
| 02/22/2007 | CA2818921A1 Method of reducing the risk of adverse cardiovascular (cv) events associated with the administration of pharmaceutical agents which favor cv events |
| 02/22/2007 | CA2770408A1 Formulations and methods for providing progestin-only contraception while minimizing adverse side effects associated therewith |
| 02/22/2007 | CA2750864A1 Bis-aryl amide compounds and methods of use |
| 02/22/2007 | CA2620612A1 Cyclic nitro compounds, pharmaceutical compositions thereof and uses thereof |
| 02/22/2007 | CA2620611A1 O-nitro compounds, pharmaceutical compositons thereof and uses thereof |
| 02/22/2007 | CA2620280A1 Novel triazole derivatives as ghrelin analogue ligands of growth hormone secretagogue receptors |
| 02/22/2007 | CA2620179A1 Inhibitors of voltage-gated sodium channels |
| 02/22/2007 | CA2619953A1 Anti-inflammatory activity of phenethylisothiocyanate (peitc) and the barbarea verna seed preparation containing this compound |
| 02/22/2007 | CA2619886A1 Conformable solvent-based bandage and coating material |
| 02/22/2007 | CA2619881A1 Chemokine receptor binding compounds |
| 02/22/2007 | CA2619832A1 Ligands for metal ions and methods for making and using the same |
| 02/22/2007 | CA2619790A1 Novel high affinity thiophene-based and furan-based kinase ligands |
| 02/22/2007 | CA2619768A1 Use of seh inhibitors as analgesics |
| 02/22/2007 | CA2619720A1 Process for the preparation of strontium ranelate |
| 02/22/2007 | CA2619704A1 Pharmaceutical compositions comprising metals for modulating epithelial cell-to-cell adhesion |
| 02/22/2007 | CA2619695A1 Therapy with cd4 binding peptides and radiation |
| 02/22/2007 | CA2619663A1 Human ribosomal dna(rdna) and ribosomal rna (rrna) nucleic acids and uses thereof |
| 02/22/2007 | CA2619659A1 Processes and intermediates |
| 02/22/2007 | CA2619643A1 Treatment of chronic renal failure and other conditions in domestic animals: compositions and methods |
| 02/22/2007 | CA2619641A1 Systemic and intrathecal effects of a novel series of phospholipase a2 inhibitors on hyperalgesia and spinal pge2 release |
| 02/22/2007 | CA2619545A1 Novel use of peptide compounds for treating muscle pain |
| 02/22/2007 | CA2619534A1 Methods and compositions for treating neurological disease |
| 02/22/2007 | CA2619517A1 Pyrazine kinase inhibitors |
| 02/22/2007 | CA2619505A1 Use of thienopyridone derivatives as ampk activators and pharmaceutical compositions containing them |
| 02/22/2007 | CA2619486A1 Crystalline and amorphous sodium atorvastatin |